Jul 25
Four Gies Business faculty featured at NBER Summer Institute
David Molitor, Tatyana Deryugina, Julian Reif, and Riley League authored research papers that were featured at the 2025 National Bureau of Economic Research (NBER) Summer Institute conference held July 7-25 in Cambridge, MA.
Jul 23
Rethinking AI through the lens of empowerment
Three Gies scholars reframe conversation by introducing a new perspective that positions AI not as a threat but a collaborative partner in human creativity.
Jul 22
Court blocks medical debt credit rule, but Gies study suggests limited impact
Judge reverses Biden-era rule, but Gies study shows eliminating medical debts from credit scores would have had little to no measurable impact on credit outcomes or likelihood of default.
Jul 14
Beyond Bedford Falls: Social media and the new bank run
Gies Professor Emeritus George Pennacchi explores how current technology – particularly social media – can impact the actions of large uninsured bank depositors and lead to bank runs.
Jul 07
Award-winning Gies research sheds light on pharma’s complex challenges
Research by Gies professor Hanu Tyagi has been recognized for its insights into the intricate dynamics of the pharmaceutical industry.
Jul 02
Are companies consistent in sociopolitical activism at home and abroad?
Research from Gies Business professor Ishva Minefee points out that support from multinational organizations -- companies with a foothold in multiple countries -- doesn’t always translate to other countries where they have a presence.
Jun 30
When pressure sparks innovation
In a surprising twist to conventional wisdom, new research from Gies Business suggests that under certain conditions, companies striving to meet earnings expectations might become more efficient – and even more innovative.
Jun 25
Three Gies Business faculty named Advanced Study Scholars
As an Advanced Study Scholar, each faculty member will receive one course release for the 2025-2026 academic year to provide additional time to pursue their research, as well as a stipend.
Jun 23
Study: Unfavorable FDA inspection outcomes associated with fewer future drug shortages
A common belief held that regulatory citations against drug manufacturing facilities led to drug shortages. A new study by Gies Business researchers Iris Wang and Gopesh Anand contradicts this belief.